Abstract
Influenza A virus (IFV) replicates its genome in the nucleus of infected cells and uses the cellular protein transport system for genome trafficking from the nucleus to the plasma membrane. However, many details of the mechanism of this process, and its relationship to subsequent cytoplasmic virus trafficking, have not been elucidated. We examined the effect of nuclear transport inhibitors Leptomycin B (LB), 5,6 dichloro-1-β-d-ribofuranosyl-benzimidazole (DRB), the vesicular transport inhibitor Brefeldin A (BFA), the caspase inhibitor ZWEHD, and microtubule inhibitor Nocodazole (NOC) on virus replication and intracellular trafficking of viral nucleoprotein (NP) from the nucleus to the ER and Golgi. Also, we carried out complementary studies to determine the effect of IFV on intracellular membranes. Inhibition of the CRM1 and TAP-P15 nuclear transport pathways by DRB and LB blocked completely the export of virus. Inhibition of vesicular trafficking by BFA, NOC, and ZWEHD also affected influenza infection. Interestingly, IFV infection induced fragmentation of the Golgi complex resulting in diffuse distribution of large and small vesicles throughout the cytoplasm. Live-cell microscopy revealed expansion of Golgi localization signals indicating progressive dispersion of Golgi positive structures, resulting in the disassembly of the Golgi ribbon structure. Other vesicular components (Rab1b, ARF1 and GBF1) were also found to be required for IFV infection. Furthermore, the exact step at which IFV infection disrupts vesicle trafficking was identified as the ER-Golgi intermediate compartment. These findings suggest that IFV NP is trafficked from the nucleus via the CRM1 and TAP pathways. IFV modulates vesicular trafficking inducing disruption of the Golgi complex. These studies provide insight on the ways in which IFV affects intracellular trafficking of different host proteins and will facilitate identification of useful pharmaceutical targets to abrogate virus replication.
Similar content being viewed by others
References
Amorim MJ, Read EK, Dalton RM, Medcalf L, Digard P. Nuclear export of influenza A virus mRNAs requires ongoing RNA polymerase II activity. Traffic. 2007;8(1):1–11.
Amorim MJ, Bruce EA, Read EKC, Foeglein A, Mahen R, Stuart AD, Digard P. Influenza A virus viral RNA mechanism for cytoplasmic transport of a Rab11- and microtubule-dependent. J Virol. 2011;85(9):4143–56.
Arcangeletti MC, Pinardi F, Missorini S, De Conto F, Conti G, Portincasa P, Scherrer K, Chezzi C. Modification of cytoskeleton and prosome networks in relation to protein synthesis in influenza A virus-infected LLC-MK2 cells. Virus Res. 1997;51:19–34.
Avalos RT, Yu Z, Nayak DP. Association of influenza virus NP and M1 proteins with cellular cytoskeletal elements in influenza virus-infected cells. J Virol. 1997;71:2947–58.
Avitabile E, Di Gaeta S, Torrisi MR, Ward PL, Roizman B, Campadelli-Fiume L. Redistribution of microtubules and Golgi apparatus in herpes simplex virus-infected cells and their role in viral exocytosis. J Virol. 1995;69(12):7472–82.
Belov GA, Feng Q, Nikovics K, Jackson CL, Ehrenfeld E. A critical role of a cellular membrane traffic protein in poliovirus RNA replication. PLoS Pathog. 2008;4(11):e1000216.
Beske O, Reichelt M, Taylor MP, Kirkegaard K, Andino R. Poliovirus infection blocks ERGIC-to-Golgi trafficking and induces microtubule-dependent disruption of the Golgi complex. J Cell Sci. 2007;120(Pt 18):3207–18.
CDC 2009. CDC estimates of 2009 H1N1 cases and related hospitalizations and deaths from April–October 17, 2009, by age group. C.f.D. Control (Ed), Emerging Infections Program (2009) (Atlanta, GA). http://www.cdc.gov/h1n1flu/estimates_2009_h1n1.htm.
Dinter A, Berger EG. Golgi-disturbing agents. Histochem Cell Biol. 1998;109:571–90.
Drecktrah D, Brown JW. Phospholipase A2 antagonists inhibit nocodazole-induced Golgi ministack formation: evidence of an ER intermediate and constitutive cycling. Mol Biol Cell. 1999;10(12):4021–32.
Guo Q, Vasile E, Krieger M. Disruptions in Golgi structure and membrane traffic in a conditional lethal mammalian cell mutant are corrected by epsilon-COP. J Cell Biol. 1994;125(6):1213–24.
Hatada E, Hasegawa M, Mukaigawa J, Shimizu K, Fukuda R. Control of influenza virus gene expression: quantitative analysis of each viral RNA species in infected cells. J Biochem (Tokyo). 1989;105:537–46.
Heuer D, Rejman Lipinski A, Machuy N, Karlas A, Wehrens A, Siedler F, Brinkmann V, Meyer TF. Chlamydia causes fragmentation of the Golgi compartment to ensure reproduction. Nature. 2009;457(7230):731–5.
Hirschberg K, Lippincott-Schwartz J. Secretory pathway kinetics and in vivo analysis of protein traffic from the Golgi complex to the cell surface. FASEB J. 1999;13(2):S251–6.
Hirschberg K, Miller CM, Ellenberg J, Presley JF, Siggia ED, Phair RD, Lippincott-Schwartz J. Kinetic analysis of secretory protein traffic and characterization of golgi to plasma membrane transport intermediates in living cells. J Cell Biol. 1998;143:1485–503.
Hsu NY, Ilnytska O, Belov G, Santiana M, Chen YH, Takvorian PM, Pau C, Van der Schaar H, Basu KN, Balla T, Cmeron CE, Ehrenfield E, Van Kappeveld JMF, Alten-Bonnet N. Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. Cell. 2010;141:799–811.
Jo S, Kawaguchi A, Takizawa N, Morikawa Y, Momose F, Nagata K. Involvement of vesicular trafficking system in membrane targeting of the progeny influenza virus genome. Microbes Infect. 2010;12(12–13):1079–84.
Kistner O, Muller K, Scholtissek C. Differential phosphorylation of the nucleoprotein of influenza A viruses. J Gen Virol. 1989;70:2421–31.
Kurokawa M, Ochiai H, Nakajima K, Niwayama S. Inhibitory effect of protein kinase C inhibitor on the replication of influenza type A virus. J Gen Virol. 1990;71:2149–55.
Lippincott-Schwartz J, Liu W. Insights into COPI coat assembly and function in living cells. Trends Cell Biol. 2006;16:e1–4.
Mahy BW, Barrett T, Briedis DJ, Brownson JM, Wolstenholme AJ. Influence of the host cell on influenza virus replication. Philos Trans R Soc Lond B Biol Sci. 1980;288:349–57.
Minor PD, Dimmock NJ. Inhibition of synthesis of influenza virus proteins: evidence of two host-cell-dependent events during multiplication. Virol. 1975;67:114–23.
Monetta P, Slavin I, Romero N, Alvarez C. Rab1b interacts with GBF1 and modulates both ARF1 dynamics and COPI association. Mol Biol Cell. 2007;18(7):2400–10.
Nayak DP, Hui EK, Barman S. Assembly and budding of influenza virus. Virus Res. 2004;106(2):147–65.
Portela A, Digard P. The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication. J Gen Virol. 2002;83:723–34.
Rust RC, Landmann L, Gosert R, Tang BL, Hong W, Hauri HP, et al. Cellular COPII proteins are involved in production of the vesicles that form the poliovirus replication complex. J Virol. 2001;75:9808–18.
Skehel JJ. Early polypeptide synthesis in influenza virus-infected cells. Virol. 1973;56:394–9.
Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179–86.
Thyberg J, Moskalewski S. Microtubules and the organization of the Golgi complex. Exp Cell Res. 1985;159:1–16.
Vogel U, Kunerl M, Scholtissek C. Influenza A virus late mRNAs are specifically retained in the nucleus in the presence of a methyltransferase or a protein kinase inhibitor. Virol. 1994;198:227–33.
Wang W, Cui ZO, Han H, Zhang ZP, Wei HP, Zhou YF, Chen Z, Zhang XE. Imaging and characterizing influenza A virus mRNA transport in living cells. Nucleic Acids Res. 2008;36(15):4913–28.
Wang S, Li H, Chen Y, Wei H, Gao GF, Liu H, Huang S, Chen JL. Transport of influenza virus neuraminidase (NA) to host cell surface is regulated by ARHGAP21 and Cdc42 proteins. J Biol Chem. 2012;287(13):9804–16.
Wessels E, Duijsings D, Niu TK, Neumann S, Oorschot VM, de Lange F, Lanke KH, Klumperman J, Henke A, Jackson CL, et al. A viral protein that blocks Arf1-mediated COP-I assembly by inhibiting the guanine nucleotide exchange factor GBF1. Dev Cell. 2006;11:191–201.
Whitney JA, Gomez M, Sheff D, Kreis TE, Mellman I. Cytoplasmic coat proteins involved in endosome function. Cell. 1995;83:703–13.
Whittaker GR. Intracellular trafficking of influenza virus: clinical implications for molecular medicine. Expert Rev Mol Med. 2001;3:1–13.
Whittaker G, Bui M, Helenius A. Nuclear trafficking of influenza virus ribonuleoproteins in heterokaryons. J Virol. 1996;70(5):2743–56.
Yamayoshi S, Neumann G, Kawaoka Y. Role of the GTPase Rab1b in ebolavirus particle formation. J Virol. 2010;84(9):4816–20.
Yang GB, Zhang LL. Roles of COPI related proteins during virus replication. Bing Du Xue Bao. 2012;28(2):185–9.
Zhang L, Lee SY, Beznoussenko GV, Peters PJ, Yang JS, Gilbert HY, Brass AL, Elledge SJ, Isaacs SN, Moss B, Mironov A, Hsu VW. A role for the host coatomer and KDEL receptor in early vaccinia biogenesis. Proc Natl Acad Sci USA. 2009;106:163–8.
Zhou Z, Mogensen MM, Powell PP, Curry S, Wileman T. Foot-and-mouth disease virus 3C Protease induces fragmentation of the Golgi Compartment and blocks intra-Golgi transport. J Virol. 2013;87(21):11721–9.
Acknowledgments
We thank Adolfo Garcia Sastre, Monty Krieger, Nihal Altan-Bonnet, Mathias P. Machner for providing NS1-GFP virus, ldlf cells, ARF1, GBF1, Rab1b plasmids.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yadav, V., Panganiban, A.T., Honer Zu Bentrup, K. et al. Influenza infection modulates vesicular trafficking and induces Golgi complex disruption. VirusDis. 27, 357–368 (2016). https://doi.org/10.1007/s13337-016-0347-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13337-016-0347-3